Baxter International (BAX) reported $11.2B in revenue for fiscal 2025, +5.7% year on year. That ranks #471 by revenue among 2853 SEC filers and #49 in Healthcare. It posted a net loss of −$957M for the same year. Revenue has grown 1.1% a year on average since 2016 ($10.2B then). The fiscal 2025 balance sheet shows $20.1B in total assets, $2.0B in cash and $9.4B in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $11.2B | +5.7% | FY20252025-12-31 |
| Gross profitGrossProfit | $3.4B | −15.2% | FY20252025-12-31 |
| Operating incomeOperatingIncomeLoss | −$308M | −$322M | FY20252025-12-31 |
| Net incomeNetIncomeLoss | −$957M | −$308M | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $845M | −17.1% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquireProductiveAssets | $513M | +15.0% | FY20252025-12-31 |
| Total assetsAssets | $20.1B | −22.2% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $6.1B | −12.0% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $2.0B | +11.5% | FY20252025-12-31 |
| Long-term debtLongTermDebt | $9.4B | −28.4% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $2.7B | −$15.0M | Open → |
| Q2 20262026-06-30 | $3.0B | $126M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 140 of 161 companies compared | −8.5% | |
| Operating marginRank 135 of 160 companies compared | −2.7% | |
| R&D as share of revenueRank 77 of 102 companies compared | 4.6% | |
| Cash as share of revenueRank 60 of 160 companies compared | 17.5% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Baxter International Inc
- Ticker
- BAX
- Exchange
- NYSE
- SIC classification
- Surgical & Medical Instruments & Apparatus (3841)
- Fiscal year end
- 12-31
- CIK
- 0000010456
Filings
- 10-QJul 30, 2026Open filing →
- 10-QApr 30, 2026Open filing →
- 10-KFeb 12, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Community Health SystemsCYH | $12.5B | $509M |
| Vertex PharmaceuticalsVRTX | $12.0B | $4.0B |
| Oscar HealthOSCR | $11.7B | −$443M |
| Baxter InternationalBAX | $11.2B | −$957M |
| Quest DiagnosticsDGX | $11.0B | $992M |
| AlconALC | $10.4B | $980M |
| Bausch Health CompaniesBHC | $10.3B | $157M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Baxter International — Key figures |url=https://companiesranked.com/en/company/baxter-international |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Baxter International — Key figures. CompaniesRanked. https://companiesranked.com/en/company/baxter-internationalBibTeX
@misc{companiesranked-en-company-baxter-international-2026,
author = {{CompaniesRanked}},
title = {{Baxter International — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/baxter-international}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-007733 · February 12, 2026
{{cite web |title=Baxter International — Key figures — 10-K (0001628280-26-007733) |url=https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/bax-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-12}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.